Welcome to LookChem.com Sign In|Join Free

CAS

  • or

1783816-74-9

Post Buying Request

1783816-74-9 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1783816-74-9 Usage

Uses

NVS PAK1 1 is one of potent and selective allosteric PAK1 inhibitors.

Biochem/physiol Actions

NVS-PAK1-1 is a potent allosteric inhibitor of p21-activated kinase PAK1, a serine-threonine kinase that is upregulated in many cancers. NVS-PAK1-1 has an IC50 value of 5 nM for dephoshorylated PAK1 and 6 nM for phosphorylated PAK1 in an in vitro dephosphorylation assay. NVS-PAK1-1 showed good selectivity against 442 other kinases including PAK2. NVS-PAK1-1 has generally good physicochemical properties, but was metabolized by rat liver microsomes, so may not be useful for in vivo work. For full characterization details, please visit the NVS-PAK1-1 probe summary on the Structural Genomics Consortium (SGC) website.To learn about other SGC chemical probes for protein targets, visit sigma.com/sgc

Check Digit Verification of cas no

The CAS Registry Mumber 1783816-74-9 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,7,8,3,8,1 and 6 respectively; the second part has 2 digits, 7 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 1783816-74:
(9*1)+(8*7)+(7*8)+(6*3)+(5*8)+(4*1)+(3*6)+(2*7)+(1*4)=219
219 % 10 = 9
So 1783816-74-9 is a valid CAS Registry Number.

1783816-74-9Downstream Products

1783816-74-9Relevant articles and documents

Optimization of a Dibenzodiazepine Hit to a Potent and Selective Allosteric PAK1 Inhibitor

Karpov, Alexei S.,Amiri, Payman,Bellamacina, Cornelia,Bellance, Marie-Helene,Breitenstein, Werner,Daniel, Dylan,Denay, Regis,Fabbro, Doriano,Fernandez, Cesar,Galuba, Inga,Guerro-Lagasse, Stephanie,Gutmann, Sascha,Hinh, Linda,Jahnke, Wolfgang,Klopp, Julia,Lai, Albert,Lindvall, Mika K.,Ma, Sylvia,M?bitz, Henrik,Pecchi, Sabina,Rummel, Gabriele,Shoemaker, Kevin,Trappe, Joerg,Voliva, Charles,Cowan-Jacob, Sandra W.,Marzinzik, Andreas L.

, p. 776 - 781 (2015)

The discovery of inhibitors targeting novel allosteric kinase sites is very challenging. Such compounds, however, once identified could offer exquisite levels of selectivity across the kinome. Herein we report our structure-based optimization strategy of

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 1783816-74-9